Viatris Inc. (VTRS)

業務介紹

Viatris Inc. 在全球範圍內經營作為一家醫療保健公司。該公司分為四個業務板塊：發達市場、大中華地區、JANZ 和新興市場。它提供處方品牌藥物、仿製藥、複雜仿製藥、生物仿製藥和活性藥物成分（API）。該公司提供各種治療領域的藥物，包括非傳染性和傳染性疾病；生物仿製藥領域包括腫瘤學、免疫學、內分泌學、眼科學和皮膚科學；以及用於抗菌、中樞神經系統藥物、抗組織胺/抗哮喘藥物、心血管藥物、抗病毒藥物、抗糖尿病藥物、抗真菌藥物和質子泵抑制劑領域的API，還提供診斷診所、教育研討會和數字工具等支持服務，以幫助患者更好地管理健康。它以口服固體劑、注射劑、複雜劑型和API的形式向零售和藥房、批發商和分銷商、支付者、保險公司和政府機構以及機構提供藥物。該公司通過藥品批發商/分銷商、藥品零售商、機構藥房、郵購和電子商務藥房以及專科藥房銷售其產品。它以Lyrica、Lipitor、Creon、Influvac、Wixela Inhub、EpiPen 自動注射器、Fraxiparine 和Yupelri；Norvasc 和Viagra；AMITIZA、Lipacreon 和Effexor；以及Celebrex 和ARV 等品牌銷售其產品，還提供生物仿製藥系列，包括Fulphila、Ogivri、Hulio 和SEMGLEE。該公司與Revance Therapeutics, Inc.、Momenta Pharmaceuticals, Inc.、Theravance Biopharma, Inc.、Biocon Ltd. 和Fujifilm Kyowa Kirin Biologics Co. Ltd. 簽訂了合作和授權協議。Viatris Inc. 成立於1961年，總部位於賓夕法尼亞州坎農斯堡。

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

公司網址

https://www.viatris.com